At a glance
- Originator Taiyo
- Class Nootropics
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 19 Dec 1996 No-Development-Reported for Cerebrovascular disorders in Japan (Unknown route)